Thalassaemia Intermedia: an Update
2009

Thalassaemia Intermedia: an Update

Sample size: 8860 publication Evidence: moderate

Author Information

Author(s): Ali T. Taher, Khaled M. Musallam, Maria D. Cappellini

Primary Institution: American University of Beirut Medical Centre

Conclusion

Our understanding of thalassaemia intermedia has significantly improved, but clear treatment guidelines are still lacking.

Supporting Evidence

  • Thalassaemia intermedia patients can experience complications unique to their condition.
  • Management options include transfusion therapy and iron chelation.
  • Pulmonary hypertension is prevalent in thalassaemia intermedia patients.

Takeaway

Thalassaemia intermedia is a blood disorder that can cause various health problems, and while we know more about it now, we still need better treatment plans.

Methodology

This review summarizes molecular and clinical characteristics of thalassaemia intermedia and discusses current treatment options.

Limitations

There are no clear guidelines for optimal management of thalassaemia intermedia.

Participant Demographics

The study included 8860 thalassaemia patients, with 2190 having thalassaemia intermedia.

Digital Object Identifier (DOI)

10.4084/MJHID.2009.004

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication